Positive results in Southampton-led patient trial for new asthma treatment – Science Codex

Positive results in Southampton-led patient trial for new asthma treatment
Science Codex
This pioneering trial investigated the potential for SNG001 to protect asthmatics from respiratory virus infections, principally the common cold, that can spread to the lung, which are a major cause of worsening asthma symptoms.
Synairgen reports positive Phase II asthma trial dataPharmaceutical Business Review
Synairgen no wheeze as asthma drug trial boosts sharesShareCast

all 13 news articles »

View full post on asthma – Google News

Positive results in Southampton-led patient trial for new asthma treatment – EurekAlert (press release)

Positive results in Southampton-led patient trial for new asthma treatment
EurekAlert (press release)
This pioneering trial investigated the potential for SNG001 to protect asthmatics from respiratory virus infections, principally the common cold, that can spread to the lung, which are a major cause of worsening asthma symptoms.
Synairgen no wheeze as asthma drug trial boosts sharesShareCast

all 11 news articles »

View full post on asthma – Google News